期刊文献+

构建促红细胞生成素表达载体及其在肾小管上皮细胞中的表达 被引量:1

Construction and expression of a pcDNA3.1(-)-hEPO vector in human proximal tubular epithelial cells
下载PDF
导出
摘要 目的构建促红细胞生成素(EPO)表达质粒,并在人近端肾小管上皮细胞中稳定表达。方法应用标准分子克隆技术构建EPO真核表达载体pcDNA3.1(-)-hEPO。磷酸钙法转染人肾小管近端上皮细胞(HK-2)。酶联免疫吸附法(ELISA)检测培养液上清中的EPO含量。MTT法绘制各组细胞生长曲线。结果构建获得EPO基因的表达质粒,并成功转染肾小管上皮细胞,后者经G418筛选,稳定表达EPO。转染后第21天,其表达量为同期转染的293细胞的(35.0±5.3)%。转染后HK-2细胞生长曲线未见明显改变。结论人近端肾小管上皮细胞可以稳定表达EPO,这为EPO基因治疗选择新靶点奠定了基础。 Objective To stably express human erythropoietin (EPO) gene in human proximal tubular epithelial cells (HK-2). Methods Eukaryotic expression vector for human EPO gene was constructed by the standard molecular cloning method. The recombinant pcDNA3.1 (-)-hEPO vector was transfected to 293 cells and HK-2 cells by the calcium phosphate coprecipitation method. EPO in cultured supernatant was detected by ELISA. Proliferation of HK-2 cells was assayed by MTT method. Results After successful construction of the recombinant plasmid and transfection of the plasmid to HK-2 cells, EPO was temporarily expressed in transfected HK-2 cells, and was constantly expressed in ttansfected HK-2 after selection by G418. The expression level of EPO in transfectcd HK- 2 cells was (35.0±5.3)% of that in transfected 293 cells. HK-2 cells stably expressing transfected human EPO did not show any changes of cell growth. Conclusion Human EPO cDNA can be stably expressed in human proximal tubular epithelial cells (HK-2), suggesting a promising approach for EPO gene therapy.
出处 《中国血液净化》 2009年第4期211-214,共4页 Chinese Journal of Blood Purification
基金 中华人民共和国人事部留学人员择优基金(2007170)
关键词 促红细胞生成素 近端肾小管上皮细胞 基因转染 基因表达 Erythropoietin Human proximal tubular epithelial cells(HK-2 cells) Gene transfection Gene expression
  • 相关文献

参考文献8

  • 1Jacobs E, Shoemaker C, Rudersdorf R, et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin[J]. Nature, 1985,318:806-810.
  • 2Erbayraktar S, Yilmaz O, Gokmen N, et al. Erythropoietin is a multifunctionaltissue-protective cytokine[J]. Curr Hematol Rep, 2003,2:465.
  • 3Galeano M, Altavilla D, Cucinotta D, et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse[J]. Deabetes, 2004. 53: 2509-2517.
  • 4Jofef P and Andrea H. Erythropoietin is more than just a promoter of Erythropoiesis[J]. J Am Soc Nephrol, 2004,15: 2240-2241.
  • 5Schaefer A, Kosa F, Bittorf T, et al. Opposite effects of inhibitors of mitogen-activated protein kinase pathways on the egr-1 and beta-globin expression in erythropoietin-responsive murine erythroleukemia cells[J].Cell Signal, 2004.16:223-234.
  • 6Wang CH, Liang CL, Huang LT, et al. Single intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats[J]. Biochem Biophys Res Commun, 2004, 314:1064-1071.
  • 7Hidefumi Mukai, Shigeru Kawakami, iitsuru Hashida. Renal press-mediated transfection method for plasmid DNA and siRNA to the kidney[J]. Biochem Biophys Res Commun, 2008, 372:383-387.
  • 8Menne J, Park 3K, Shushakova N, et al. Continuous erythropoietin receptor activation affects different pathways of diabetic renal injury[J]. 3 Am Soc Nephrol, 2007,18: 2046-2053.

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部